| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/23/2011 | CN101979014A Medicament for treating psoriasis |
| 02/23/2011 | CN101979001A Traditional Chinese medicine for treating early white hair |
| 02/23/2011 | CN101978996A Traditional Chinese medicinal composition for preventing and treating sunburn and preparation method of cream thereof and cream thereof |
| 02/23/2011 | CN101978993A Composition for nourishing and blackening hair |
| 02/23/2011 | CN101978991A External Chinese medicinal liquor for treating body odor |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978974A Method for extracting bioactive substance by breaking walls of chlorella pyrenoidosa chick |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101978910A Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
| 02/23/2011 | CN101220092B Human keratinized cell growth factor-1 analogue preparation method and application thereof |
| 02/23/2011 | CN101132801B Composition for preparing carbon dioxide preparation for external use |
| 02/22/2011 | US7894769 Wireless microphone communication system |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893215 Agonist antibodies to IL-23 receptor |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893078 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7892574 Topical administration of oxazolidinones for transdermal delivery |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
| 02/22/2011 | CA2392685C Antisense antibacterial method and composition |
| 02/17/2011 | WO2011019617A2 Vitamin d3 and analogs thereof for treating alopecia |
| 02/17/2011 | WO2011019239A2 Composition containing a natural extract |
| 02/17/2011 | WO2011019060A1 Hedgehog signal inhibitor |
| 02/17/2011 | WO2011018885A1 Preparation for external application to skin, skin whitening agent, antioxidant agent, and anti-aging agent |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011017909A1 Pharmaceutical solution of cetirizine hydrochloride |
| 02/17/2011 | WO2010123759A9 Compositions and methods for treating burns |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | US20110039946 Method of improving atopic dermatological diseases, in which a composition comprising magnolol, honokiol or a combination thereof is administered to a patient with atopic dermatological diseases |
| 02/17/2011 | US20110039943 Methods for treating skin disorders with topical nitrogen mustard compositions |
| 02/17/2011 | US20110039927 Compositions comprising and processes for producing inorganic salts of hop acids |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110039845 2-aminoquinazoline derivative |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039838 Pyrrolotriazine compounds as kinase inhibitors |
| 02/17/2011 | US20110039822 Heterocyclic janus kinase 3 inhibitors |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | US20110039801 Nk1 receptor antagonist composition |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110039778 Peptide Synthesis |
| 02/17/2011 | US20110038970 Process for Preparing Sapucainha Oil or Butter, Cosmetic or Pharmaceutical Composition and Use of the Sapucainha Oil or Butter |
| 02/17/2011 | US20110038956 Selenium-containing compositions and uses thereof |
| 02/17/2011 | US20110038953 Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/17/2011 | US20110038946 Release of antibiotic from injectable, biodegradable polyurethane scaffolds for enhanced bone fracture healing |
| 02/17/2011 | US20110038921 Methods and compositions for temporal release of agents from a biodegradable scaffold |
| 02/17/2011 | US20110038920 Wound healing compositions and treatments |
| 02/17/2011 | US20110038917 Therapeutic compositions and methods for treating gram-negative bacterial infections |
| 02/17/2011 | US20110038904 Gel Product |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038882 Methods for Treating Allergic Disease |
| 02/17/2011 | US20110038867 Remedies for pemphigus containing anti fas ligand antibodies |
| 02/17/2011 | US20110038856 Methods of treating neoplastic, autoimmune and inflammatory diseases |
| 02/17/2011 | US20110038853 Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis |
| 02/17/2011 | US20110038847 Process for preparing bioabsorbable sheet preparation holding thrombin |
| 02/17/2011 | US20110038830 Cosmetic use of plakoglobin-type proteins |
| 02/17/2011 | US20110038828 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 02/17/2011 | US20110038814 Tryptase inhibiting mustard extract |
| 02/17/2011 | DE102009026357A1 Mixed oxide dispersion in water, where mixed oxide contains silicon, sodium, and either potassium, calcium, phosphorus and/or magnesium, useful to manufacture or prepare a food-, pharmaceutical- or cosmetic product |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2770683A1 Vitamin d3 and analogs thereof for treating alopecia |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284172A1 Immunomodulating heterocyclic compounds |
| 02/16/2011 | EP2284160A1 Pyrimidine derivative having cell-protecting activity and use thereof |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283807A1 Moisturizing agent |
| 02/16/2011 | EP2283130A1 DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2282759A2 Use of nucleic acids with reduced pressure therapy for treating wounds |
| 02/16/2011 | EP2282733A2 Protection of normal cells |
| 02/16/2011 | EP2282732A2 Use of olive oil extract to control skin aging |
| 02/16/2011 | EP2282731A1 Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel |
| 02/16/2011 | CN1846456B Communication system for wireless microphone |
| 02/16/2011 | CN101977931A Polypeptide and pharmaceutical composition containing the polypeptide |
| 02/16/2011 | CN101977626A Use of serine protease inhibitors in the treatment of skin diseases |
| 02/16/2011 | CN101977618A Composition for treating a skin disorder |
| 02/16/2011 | CN101977602A Immunosuppressive macrolide powder for oral suspension |
| 02/16/2011 | CN101977601A Compositions comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting same |
| 02/16/2011 | CN101977599A Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| 02/16/2011 | CN101977589A Chitosan gel for dermatological use, production method therefor and use of same |
| 02/16/2011 | CN101974390A Anti-ageing Chinese medicament healthcare wine and preparation method thereof |
| 02/16/2011 | CN101974068A Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101973925A 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof |
| 02/16/2011 | CN101972489A Novel wound self-healing biological material, preparation method and application thereof |
| 02/16/2011 | CN101972483A RNAI-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |